Latest US Food and Drug Association Stories

Adcetris, manufactured by Seattle Genetics, a new treatment for anaplastic large cell lymphoma and the first approved treatment for Hodgkin’s lymphoma since 1977, has been approved by the US Food and Drug Association (FDA). Seattle Genetics told Reuters on Monday that the drug will cost $4,500 dollars per vial. Patients generally received three vials per dose and between seven and nine doses per treatment, putting the price at $94,500 to $121,500 per patient, within Wall Street’s...